These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19240179)

  • 1. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
    Sharpless NE; Alson S; Chan S; Silver DP; Castrillon DH; DePinho RA
    Cancer Res; 2002 May; 62(10):2761-5. PubMed ID: 12019151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication.
    Zannetti C; Mondini M; De Andrea M; Caposio P; Hara E; Peters G; Gribaudo G; Gariglio M; Landolfo S
    Virology; 2006 May; 349(1):79-86. PubMed ID: 16504234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock.
    Munro J; Barr NI; Ireland H; Morrison V; Parkinson EK
    Exp Cell Res; 2004 May; 295(2):525-38. PubMed ID: 15093749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
    Kim YJ; Jung JK; Lee SY; Jang KL
    Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
    Kim LH; Peh SC; Poppema S
    Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETS-dependent p16INK4a and p21waf1/cip1 gene expression upon endothelin-1 stimulation in malignant versus and non-malignant proximal tubule cells.
    von Brandenstein M; Schlosser M; Richter C; Depping R; Fries JW
    Life Sci; 2012 Oct; 91(13-14):562-71. PubMed ID: 22521293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two mechanisms underlying the loss of p16(Ink4a) function are associated with distinct tumorigenic consequences for WS MEFs escaping from senescence.
    Wu X; Jia S; Zhang X; Si X; Tang W; Luo Y
    Mech Ageing Dev; 2012 Aug; 133(8):549-55. PubMed ID: 22813853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas.
    Polsky D; Young AZ; Busam KJ; Alani RM
    Cancer Res; 2001 Aug; 61(16):6008-11. PubMed ID: 11507043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?
    Soussi T; Hjortsberg L
    Trends Mol Med; 2009 Jan; 15(1):1-4. PubMed ID: 19097939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light.
    Al-Mohanna MA; Al-Khalaf HH; Al-Yousef N; Aboussekhra A
    Nucleic Acids Res; 2007; 35(1):223-33. PubMed ID: 17158160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell ageing is uncoupled from p16 INK4A-mediated senescence.
    Attema JL; Pronk CJ; Norddahl GL; Nygren JM; Bryder D
    Oncogene; 2009 Jun; 28(22):2238-43. PubMed ID: 19398954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence.
    Li H; Wang W; Liu X; Paulson KE; Yee AS; Zhang X
    Oncogene; 2010 Sep; 29(36):5083-94. PubMed ID: 20581871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.
    Gizard F; Amant C; Barbier O; Bellosta S; Robillard R; Percevault F; Sevestre H; Krimpenfort P; Corsini A; Rochette J; Glineur C; Fruchart JC; Torpier G; Staels B
    J Clin Invest; 2005 Nov; 115(11):3228-38. PubMed ID: 16239970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
    Gadd M; Pisc C; Branda J; Ionescu-Tiba V; Nikolic Z; Yang C; Wang T; Shackleford GM; Cardiff RD; Schmidt EV
    Cancer Res; 2001 Dec; 61(24):8811-9. PubMed ID: 11751403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16
    Al-Khalaf HH; Nallar SC; Kalvakolanu DV; Aboussekhra A
    Mol Carcinog; 2017 Jul; 56(7):1687-1702. PubMed ID: 28218424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.